VIVENTIA BIO INC.
Patent Owner
Stats
- 16 US PATENTS IN FORCE
- 0 US APPLICATIONS PENDING
- Nov 21, 2017 most recent publication
Details
- 16 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 162 Total Citation Count
- Jun 21, 1994 Earliest Filing
- 4 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
- No Recent Publications to Display
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9109223 Methods for generating and screening fusion protein libraries and uses thereofDec 22, 06Aug 18, 15[C12P, C12N, G01N, C40B, C07K]
8999334 Antibody conjugates against variant NFKBIB and uses thereofMar 26, 13Apr 07, 15[A61K, G01N, C07K]
8426561 Antibodies against a cancer-associated epitope of variant NFKBIB and uses thereofNov 27, 08Apr 23, 13[C07K]
8318472 Optimized nucleic acid sequences for the expression of VB4-845Sep 26, 08Nov 27, 12[C12N, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2016/0060,352 COMPOSITIONS AND METHODS FOR DETECTION AND TREATMENT OF HEPATOCELLULAR CARCINOMAAbandonedApr 14, 14Mar 03, 16[A61K, G01N, C07K]
2013/0039,931 Antibodies Against A Cancer-Associated Epitope of Variant HNRNPG and Uses ThereofAbandonedAug 22, 12Feb 14, 13[A61K, C07H, C12N, G01N, A61P, C07K]
7166286 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for prophylaxis and detection of cancersExpiredAug 29, 03Jan 23, 07[A61K]
7115722 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancersExpiredMay 22, 97Oct 03, 06[C07H]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.